Europe Diabetes Devices Market Size & Outlook, 2023-2030

The diabetes devices market in Europe is expected to reach a projected revenue of US$ 15,109.9 million by 2030. A compound annual growth rate of 7.1% is expected of Europe diabetes devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$9,355.9
Forecast, 2030 (US$M)
$15,109.9
CAGR, 2024 - 2030
7.1%
Report Coverage
Europe

Europe diabetes devices market highlights

  • The Europe diabetes devices market generated a revenue of USD 9,355.9 million in 2023.
  • The market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
  • In terms of segment, insulin delivery devices was the largest revenue generating type in 2023.
  • Insulin Delivery Devices is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 9,355.9 million
Market revenue in 2030USD 15,109.9 million
Growth rate7.1% (CAGR from 2023 to 2030)
Largest segmentInsulin delivery devices
Fastest growing segmentInsulin Delivery Devices
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBlood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices
Key market players worldwideMedtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray


Other key industry trends

  • In terms of revenue, Europe region accounted for 30.9% of the global diabetes devices market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 11,876.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Diabetes Devices Market Scope

Diabetes devices market segmentation & scope
Blood Glucose Meters
Testing Strips
Lancets
Sensors
Transmitters
Receiver
Pumps
Pens
Syringes
Jet Injectors
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others
Hospitals
Homecare
Diagnostic Centers

Diabetes Devices Market Companies

Name Profile # Employees HQ Website

Europe diabetes devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.


Insulin delivery devices was the largest segment with a revenue share of 54.19% in 2023. Horizon Databook has segmented the Europe diabetes devices market based on blood glucose monitoring (bgm) devices, insulin delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.


Increasing prevalence of diabetes and rising awareness about diabetes management & control are among the factors expected to contribute to the growth of this market over the forecast period. According to International Diabetes Federation report (2021), approximately 61 million people in Europe suffer from diabetes, which accounts for around one in 11 adults. Russian Federation, Germany. 

The diabetes devices market in Europe is smaller than in North America, with some European countries exhibiting less than 5% market penetration. The difference in the market size of the two regions can be attributed to unfavorable reimbursement policies, market access issues of insulin pumps, and a lack of trained professionals in many European countries. 

However, countries like Germany and France have over 15% penetration of insulin pumps compared to less than 5% in other EU countries. In 2021, Medtronic plc was the leading player in the diabetes devices market in the region. Other key players in the region include Hoffmann-La Roche AG, Ypsomed AG, and Insulet Corporation. Ypsomed AG is a key distributor of Insulin pumps in Europe.

Reasons to subscribe to Europe diabetes devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe diabetes devices market databook

  • Our clientele includes a mix of diabetes devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe diabetes devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe diabetes devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe diabetes devices market size, by country, 2018-2030 (US$M)

Europe Diabetes Devices Market Outlook Share, 2023 & 2030 (US$M)

Europe diabetes devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more